Rakovina Therapeutics Inc.
No bio yet
This person is not in any teams
This person is not in any offices
Rakovina Therapeutics Inc.
Rakovina Therapeutics’ focus is the development of new cancer treatments based on novel DNA-damage response technologies. The Company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics fromHealth Canada, the United States Food and Drug Administration and similar international regulatory agencies